疾病控制多发性骨髓瘤在一个患者17p增益和t(4;14):一个病例报告
Xinyu Tang1, Ruirong Xu2,3,4, Wei Zheng2,3,4
1The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, China.
Heliyon
|April 10, 2024
概括
高风险多发性骨髓瘤 (MM) 细胞遗传学,包括17p增益和t(4;14),影响预后. 本案例研究探讨了17p增加对MM预后和治疗的影响,表明它可能并不总是表明结果不佳.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 细胞遗传异常,如t(4;14),del(17p) 和TP53突变,与高风险的多发性骨髓瘤 (MM) 和不良预后有关.
- 目前关于MM细胞遗传学的文献是不完整的,对17p增益及其预后意义的关注有限,特别是在t{\displaystyle t};{\displaystyle t};{\displaystyle t};{\displaystyle t};{\displaystyle t};{\displaystyle t}
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K